133 related articles for article (PubMed ID: 29044540)
1. Factors affecting hospital length of stay following pelvic exenteration surgery.
Guo Y; Chang E; Bozkurt M; Park M; Liu D; Fu JB
J Surg Oncol; 2018 Mar; 117(3):529-534. PubMed ID: 29044540
[TBL] [Abstract][Full Text] [Related]
2. Urological leaks after pelvic exenterations comparing formation of colonic and ileal conduits.
Teixeira SC; Ferenschild FT; Solomon MJ; Rodwell L; Harrison JD; Young JM; Vasilaras A; Eisinger D; Lee P; Byrne C
Eur J Surg Oncol; 2012 Apr; 38(4):361-6. PubMed ID: 22265840
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of colorectal anastomoses during pelvic exenteration for gynaecological malignancy.
Lim SW; Lim SB; Park JY; Park SY; Choi HS; Jeong SY
Br J Surg; 2008 Jun; 95(6):770-3. PubMed ID: 18418859
[TBL] [Abstract][Full Text] [Related]
4. Performance and outcome of pelvic exenteration for gynecologic malignancies: A population-based study.
Matsuo K; Mandelbaum RS; Adams CL; Roman LD; Wright JD
Gynecol Oncol; 2019 May; 153(2):368-375. PubMed ID: 30792003
[TBL] [Abstract][Full Text] [Related]
5. Complications after double-barreled wet colostomy compared to separate urinary and fecal diversion during pelvic exenteration: time to change back?
Backes FJ; Tierney BJ; Eisenhauer EL; Bahnson RR; Cohn DE; Fowler JM
Gynecol Oncol; 2013 Jan; 128(1):60-64. PubMed ID: 22892363
[TBL] [Abstract][Full Text] [Related]
6. Pelvic exenteration: long-term oncological results in a series of 106 patients.
De Wever I
Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128
[TBL] [Abstract][Full Text] [Related]
7. [Pelvic exenteration of advanced gynecological malignacies: a report of 18 cases].
Zhang Z; Zang R; Chen J
Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):288-90. PubMed ID: 11775910
[TBL] [Abstract][Full Text] [Related]
8. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.
Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR
Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266
[TBL] [Abstract][Full Text] [Related]
9. Laparoscopic pelvic exenteration for advanced pelvic cancers: a review of 16 cases.
Puntambekar S; Kudchadkar RJ; Gurjar AM; Sathe RM; Chaudhari YC; Agarwal GA; Rayate NV
Gynecol Oncol; 2006 Sep; 102(3):513-6. PubMed ID: 16510172
[TBL] [Abstract][Full Text] [Related]
10. [Laparoscopy-assisted vaginal pelvic exenteration].
Ferron G; Querleu D; Martel P; Chopin N; Soulié M
Gynecol Obstet Fertil; 2006 Dec; 34(12):1131-6. PubMed ID: 17134933
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of pelvic exenteration for locally advanced primary rectal cancer: Overall survival and quality of life.
Quyn AJ; Austin KK; Young JM; Badgery-Parker T; Masya LM; Roberts R; Solomon MJ
Eur J Surg Oncol; 2016 Jun; 42(6):823-8. PubMed ID: 26947962
[TBL] [Abstract][Full Text] [Related]
12. Complications of pelvic exenteration in children who have genitourinary rhabdomyosarcoma.
Michalkiewicz EL; Rao BN; Gross E; Luo X; Bowman LC; Pappo AS; Kaste SC; Hudson MM; Greenwald CA; Jenkins JJ; Pratt CB
J Pediatr Surg; 1997 Sep; 32(9):1277-82. PubMed ID: 9314242
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.
Fotopoulou C; Neumann U; Kraetschell R; Schefold JC; Weidemann H; Lichtenegger W; Sehouli J
J Surg Oncol; 2010 May; 101(6):507-12. PubMed ID: 20401918
[TBL] [Abstract][Full Text] [Related]
14. Influence of tumor size on outcomes following pelvic exenteration.
Smith B; Jones EL; Kitano M; Gleisner AL; Lyell NJ; Cheng G; McCarter MD; Abdel-Misih S; Backes FJ
Gynecol Oncol; 2017 Nov; 147(2):345-350. PubMed ID: 28822555
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopy-assisted vaginal pelvic exenteration.
Ferron G; Querleu D; Martel P; Letourneur B; Soulié M
Gynecol Oncol; 2006 Mar; 100(3):551-5. PubMed ID: 16249020
[TBL] [Abstract][Full Text] [Related]
16. Omental flap after pelvic exenteration for pelvic cancer.
Miyamoto Y; Akiyama T; Sakamoto Y; Tokunaga R; Ohuchi M; Shigaki H; Kurashige J; Iwatsuki M; Baba Y; Yoshida N; Baba H
Surg Today; 2016 Dec; 46(12):1471-1475. PubMed ID: 27226018
[TBL] [Abstract][Full Text] [Related]
17. Pelvic exenteration as treatment of recurrent or advanced gynecologic and urologic cancer.
Roos EJ; Van Eijkeren MA; Boon TA; Heintz AP
Int J Gynecol Cancer; 2005; 15(4):624-9. PubMed ID: 16014116
[TBL] [Abstract][Full Text] [Related]
18. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
Jäger L; Nilsson PJ; Rådestad AF
Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
[TBL] [Abstract][Full Text] [Related]
19. Impact of flap reconstruction on perineal wound complications following ablative surgery for advanced and recurrent rectal cancers.
Davidge KM; Raghuram K; Hofer SO; Ferguson PC; Wunder JS; Swallow CJ; Zhong T
Ann Surg Oncol; 2014 Jun; 21(6):2068-73. PubMed ID: 24522990
[TBL] [Abstract][Full Text] [Related]
20. Total laparoscopic pelvic exenteration for a laterally recurrent cervical carcinoma with a vesicovaginal fistula that developed after concurrent chemoradiotherapy.
Kanao H; Aoki Y; Hisa T; Takeshima N
Gynecol Oncol; 2017 Aug; 146(2):438-439. PubMed ID: 28576262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
